ArriVent BioPharma, Inc.'s market cap is currently $724.56M. The company's EPS TTM is $-0.9; its P/E ratio is ―; ArriVent BioPharma, Inc. is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Currency in USD
ArriVent BioPharma, Inc. Earnings and Revenue History
